Multiple Sclerosis Intimacy and Sexuality Questionnaire
The Multiple Sclerosis Intimacy and Sexuality Questionnaire-15 (MSISQ-15): Validation of the Turkish Version in Patients With Multiple Sclerosis
1 other identifier
observational
130
1 country
1
Brief Summary
Aims: This study aimed to psychometrically evaluate the Turkish version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ-15) in women with MS. Methods: The study included 130 women with MS. The Turkish linguistic validation process of the original English MSISQ-15 was performed according to standardized guidelines. Reliability analysis was evaluated with test-retest analysis and intra-class correlation (ICC). Internal consistency between the items was analyzed using the Cronbach's alpha coefficient. Item analysis results were used to assess the contribution of the items to the scale. In evaluating the validity of the scale, the relationship between the MSISQ and the Female Sexual Function Index (FSFI), the Multiple Sclerosis Quality of Life Questionnaire-54 (MSQOL-54), and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PSIQ-12) was investigated. Psychometric properties were analyzed using internal consistency, test-rest reliability, construct validity, and floor-ceiling effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2022
CompletedFirst Submitted
Initial submission to the registry
May 2, 2022
CompletedFirst Posted
Study publicly available on registry
May 13, 2022
CompletedMay 13, 2022
May 1, 2022
4 months
May 2, 2022
May 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Questionnaire
Multiple Sclerosis Intimacy and Sexuality Scale is a 15-item self-report measure that assesses the impact of MS symptoms on sexual activity and satisfaction over the past 6 months.Higher scores indicate greater sexual problems.
day 1
Questionnaire
Female Sexual Function Index is a 19-item scale that evaluates the sexual functions of female patients. The questionnaire consists of 6 separate subdimensions: desire, arousal, lubrication, orgasm, satisfaction, and pain. Higher scores indicate better sexual function.
day 1
Questionnaire
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire is an instrument that evaluates sexual function in women with urinary incontinence and/or pelvic organ prolapse. Increasing scores indicate better sexual function.
day 1
Questionnaire
Global Pelvic Floor Bother Questionnaire is used to evaluate the presence and severity of the most common clinical problems caused by the pelvic floor dysfunction, namely, stress urinary incontinence, frequent and sudden urination sensation, urge incontinence, voiding difficulty, pelvic organ prolapse, obstructive defecation, fecal incontinence, and dyspareunia. A high score indicates more pelvic floor symptom complaints.
day 1
Questionnaire
Multiple Sclerosis Quality of Life Questionnaire-54 is used to evaluate the quality of life of patients with MS. Higher scores indicate better quality of life.
day 1
Interventions
descriptive study
Eligibility Criteria
Multiple Sclerosis women
You may qualify if:
- Women over the age of 18 who were literate,
- who did not have any mental problems preventing cooperation and understanding,
- who were diagnosed with MS
You may not qualify if:
- Having pelvic organ prolapse stage 2 or more;
- having a history of relapse in the past 30 days;
- experiencing loss of balance or gait disturbance caused by a condition other than MS;
- being pregnant; having a history of gynecological, urological and/or neurological surgery;
- having a history of cesarean or vaginal birth in the past six months;
- being sexually inactive; and, having urinary tract infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bozok Universitylead
Study Sites (1)
Yozgat Bozok University
Yozgat, 66000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 2, 2022
First Posted
May 13, 2022
Study Start
August 12, 2021
Primary Completion
December 10, 2021
Study Completion
March 10, 2022
Last Updated
May 13, 2022
Record last verified: 2022-05